Rosetta Genomics Ltd (NASDAQ:ROSG)

3.92
Delayed Data
As of Apr 17
 +0.14 / +3.70%
Today’s Change
2.07
Today|||52-Week Range
5.55
+73.45%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +40.31% increase from the last price of 3.92.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Rosetta Genomics Ltd. This rating has held steady since April, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$150.0K
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.78%
 
 
 
 
 
 
Growthannually -197.52%
 
 
 
 
 
 

Sales

Growthquarterly 50.00%
 
 
 
 
 
 
Growthannually 282.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account